{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:45:04Z","timestamp":1789609504363,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-026-06808-4","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T15:16:13Z","timestamp":1775747773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of vancomycin sensitive and resistant enterococcal infection in children"],"prefix":"10.1186","volume":"26","author":[{"given":"Hacer","family":"Yakin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilge","family":"Acikalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman Oguz","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kubra","family":"Aykac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulsen","family":"Hazirolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Bulent","family":"Cengiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Ozsurekci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"6808_CR1","unstructured":"Levitus M, Rewane A, Perera TB, Vancomycin-Resistant E. 2023 Jul 17. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2025. PMID: 30020605."},{"key":"6808_CR2","doi-asserted-by":"publisher","unstructured":"Clinical Characteristics and Outcomes of Immunocompromised Patients with Enterococcal Pneumonia. 2022;9(Suppl 2):ofac492.1791. https:\/\/doi.org\/10.1093\/ofid\/ofac492.1791","DOI":"10.1093\/ofid\/ofac492.1791"},{"key":"6808_CR3","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Solache M, Rice LB. The Enterococcus: A Model of Adaptability to Its Environment. Clin Microbiol Rev 2019, 32. [CrossRef].","DOI":"10.1128\/CMR.00058-18"},{"key":"6808_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jiac.2018.01.001","volume":"24","author":"J Monticelli","year":"2018","unstructured":"Monticelli J, Knezevich A, Luzzati R, Di Bella S. Clinical Management of Non-Faecium Non-Faecalis Vancomycin-Resistant Enterococci Infection. Focus on Enterococcus Gallinarum and Enterococcus Casseliflavus\/flavescens. J Infect Chemother. 2018;24:237\u201346. [CrossRef].","journal-title":"J Infect Chemother"},{"key":"6808_CR5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3390\/biology11040598","volume":"11","author":"DA Toc","year":"2022","unstructured":"Toc DA, Pandrea SL, Botan A, Mihaila RM, Costache CA, Colosi IA, Junie LM. Enterococcus Raffinosus, Enterococcus Durans and Enterococcus Avium Isolated from a Tertiary Care Hospital in Romania-Retrospective Study and Brief Review. Biology. 2022;11:598. [CrossRef].","journal-title":"Biology"},{"key":"6808_CR6","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1128\/AEM.66.5.2263-2266.2000","volume":"66","author":"A Sghir","year":"2000","unstructured":"Sghir A, Gramet G, Suau A, Rochet V, Pochart P, Dore J. Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl Environ Microbiol. 2000;66:2263\u20136.","journal-title":"Appl Environ Microbiol"},{"key":"6808_CR7","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1126\/science.1110591","volume":"308","author":"PB Eckburg","year":"2005","unstructured":"Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science. 2005;308:1635\u20138.","journal-title":"Science"},{"key":"6808_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jgar.2018.08.016","volume":"16","author":"T Lee","year":"2019","unstructured":"Lee T, Pang S, Abraham S, Coombs GW. Antimicrobial-resistant CC17 Enterococcus faecium: The past, the present and the future. J Glob Antimicrob Resist. 2019;16:36\u201347. [PubMed] [Ref list].","journal-title":"J Glob Antimicrob Resist"},{"issue":"9","key":"6808_CR9","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1017\/ice.2018.146","volume":"39","author":"H McDermott","year":"2018","unstructured":"McDermott H, Skally M, O\u2019Rourke J, Humphreys H, Fitzgerald-Hughes D. Near-patient environmental contamination of an intensive care unit with Vancomycin-resistant Enterococci (VRE) and Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (ESBL-E) before and after the introduction of chlorhexidine bathing for patients. Infect Control Hosp Epidemiol. 2018;39(9):1131\u20132. [PubMed][Ref list].","journal-title":"Infect Control Hosp Epidemiol"},{"key":"6808_CR10","unstructured":"CDC. Antibiotic Resistance Threats in the United States, A., GA: & U.S. Department of Health and Human Services, C. Available online: https:\/\/www.cdc.gov\/drugresistance\/pdf\/threats-report\/2019-ar-threats-report-508.pdf (Accessed on 1 October 2022)."},{"key":"6808_CR11","first-page":"341","volume":"174","author":"ECDC","year":"2020","unstructured":"ECDC. Antimicrobial resistance in the EU\/EEA (EARS-Net) Annual Epidemiological Report for 2019. Epidemiolog Antimicrob Resist EU\/EEA. 2020;174:341.","journal-title":"Epidemiolog Antimicrob Resist EU\/EEA"},{"key":"6808_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","volume":"19","author":"A Cassini","year":"2018","unstructured":"Cassini A, H\u00f6gberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, Colomb-Cotinat M, Kretzschmar ME, Devleesschauwer B, Cecchini M, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic- resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis. Lancet Infect Dis. 2018;19:56\u201366. [CrossRef] [PubMed].","journal-title":"Lancet Infect Dis"},{"key":"6808_CR13","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1080\/22221751.2020.1769500","volume":"9","author":"O Ayobami","year":"2020","unstructured":"Ayobami O, Willrich N, Reuss A, Eckmanns T, Markwart R. The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: An epidemiological analysis of bloodstream infections. Emerg Microbes Infect. 2020;9:1180\u201393. [CrossRef] [PubMed].","journal-title":"Emerg Microbes Infect"},{"key":"6808_CR15","unstructured":"WHO Bacterial. Priority Pathogens List, 2024."},{"key":"6808_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.7883\/yoken.65.146","volume":"65","author":"A Inan","year":"2012","unstructured":"Inan A, Ozgultekin A, Akcay SS, et al. Jpn J Infect Dis. 2012;65:146\u201351.","journal-title":"Jpn J Infect Dis"},{"key":"6808_CR17","unstructured":"WHO CAESAR. Annual Report 2023."},{"issue":"4","key":"6808_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1001\/jama.1963.03060040057022","volume":"185","author":"EM Ory","year":"1963","unstructured":"Ory EM, Yow EM. The Use and Abuse of the Broad Spectrum Antibiotics. JAMA. 1963;185(4):273\u20139. https:\/\/doi.org\/10.1001\/jama.1963.03060040057022.","journal-title":"JAMA"},{"issue":"6","key":"6808_CR19","first-page":"618","volume":"56","author":"A \u00d6zkaya-Parlakay","year":"2014","unstructured":"\u00d6zkaya-Parlakay A, Cengiz AB, Ceyhan M, et al. Vancomycin-resistant enterococcus colonization and infection in children: six-year follow-up. Turk J Pediatr. 2014;56(6):618\u201325.","journal-title":"Turk J Pediatr"},{"issue":"3","key":"6808_CR20","doi-asserted-by":"publisher","first-page":"116324","DOI":"10.1016\/j.diagmicrobio.2024.116324","volume":"109","author":"DD Gumus","year":"2024","unstructured":"Gumus DD, Demir OO, Aykac K, Hazirolan G, Avci H, Ceyhan M, Cengiz AB, Ozsurekci Y. Gram-negative bacteremia, the risk factors, and outcome in children. Diagn Microbiol Infect Dis. 2024;109(3):116324. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116324. Epub 2024 Apr 23. PMID: 38733752.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"6808_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.diagmicrobio.2016.12.013","volume":"87","author":"Y Ozsurekci","year":"2017","unstructured":"Ozsurekci Y, Aykac K, Cengiz AB, Basaranoglu ST, Sancak B, Karahan S, Kara A, Ceyhan M. Bloodstream infections in children caused by carbapenem-resistant versus carbapenem- susceptible gram-negative microorganisms: Risk factors and outcome. Diagn Microbiol Infect Dis. 2017;87(4):359\u201364.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"6808_CR23","unstructured":"Gordon M, Lumley T. _forestplot: Advanced Forest Plot Using \u2018grid\u2019 Graphics_. R package version 3.1.3. 2023."},{"key":"6808_CR24","unstructured":"Therneau T. _A Package for Survival Analysis in R_. R package version. 2023;3.5-5.https:\/\/CRAN.R-project.org\/package=survival"},{"key":"6808_CR25","unstructured":"Kassambara A, Kosinski M, Biecek P. _survminer: Drawing Survival Curves using \u2018ggplot2\u2019_. R package version. 0.4.9. 2021. https:\/\/CRAN.R-project.org\/package=survminer"},{"key":"6808_CR26","doi-asserted-by":"crossref","unstructured":"Weiner-Lastinger LM, Abner S, Edwards JR, Kallen AJ, Karlsson M, Magill SS, Pollock D, See I, Soe MM, Walters MS, et al. Infect Control Hosp Epidemiol. 2020;41:2015\u20137. Antimicrobial-Resistant Pathogens Associated with Adult Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network.","DOI":"10.1017\/ice.2019.296"},{"key":"6808_CR27","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1017\/ice.2016.174","volume":"37","author":"LM Weiner","year":"2016","unstructured":"Weiner LM, Webb AK, Limbago B, Dudeck MA, Patel J, Kallen AJ, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011\u20132014. Infect Control Hosp Epidemiol. 2016;37:1288\u2013301.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"6808_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/668770","volume":"34","author":"DM Sievert","year":"2013","unstructured":"Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, et al. National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009\u20132010. Infect Control Hosp Epidemiol. 2013;34:1\u201314.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"6808_CR29","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3201\/eid1305.061421","volume":"13","author":"J Cuellar-Rodr\u00edguez","year":"2007","unstructured":"Cuellar-Rodr\u00edguez J, Galindo-Fraga A, Guevara V, P\u00e9rez-Jim\u00e9nez C, Espinosa-Aguilar L, Rol\u00f3n AL, et al. Vancomycin-resistant enterococci, Mexico City. Emerg Infect Dis. 2007;13:798\u20139.","journal-title":"Emerg Infect Dis"},{"key":"6808_CR30","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jgar.2020.12.005","volume":"24","author":"BA L\u00f3pez-Luis","year":"2021","unstructured":"L\u00f3pez-Luis BA, Sifuentes-Osornio J, Lambra\u00f1o-Castillo D, et al. Risk factors and outcomes associated with vancomycin-resistant Enterococcus faecium and ampicillin-resistant Enterococcus faecalis bacteraemia: A 10-year study in a tertiary-care centre in Mexico City. J Glob Antimicrob Resist. 2021;24:198\u2013204. https:\/\/doi.org\/10.1016\/j.jgar.2020.12.005.","journal-title":"J Glob Antimicrob Resist"},{"issue":"Suppl 2","key":"6808_CR31","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1093\/cid\/ciy657","volume":"67","author":"F Hu","year":"2018","unstructured":"Hu F, Zhu D, Wang F, Wang M. Current status and trends of antibacterial resistance in China. Clin Infect Dis. 2018;67(Suppl 2):S128\u201334.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"6808_CR32","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s100960000390","volume":"19","author":"MA Schouten","year":"2000","unstructured":"Schouten MA, Hoogkamp-Korstanje JA, Meis JF, Voss A, European VRE, Study Group. Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis. 2000;19(11):816\u201322. https:\/\/doi.org\/10.1007\/s100960000390.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"6808_CR33","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3390\/antibiotics13070601","volume":"13","author":"V Zerbato","year":"2024","unstructured":"Zerbato V, Pol R, Sanson G, et al. Risk Factors for 30-Day Mortality in Nosocomial Enterococcal Bloodstream Infections. Antibiot (Basel). 2024;13(7):601. Published 2024 Jun 27.","journal-title":"Antibiot (Basel)"},{"issue":"7","key":"6808_CR34","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1086\/339211","volume":"34","author":"TP Lodise","year":"2002","unstructured":"Lodise TP, McKinnon PS, Tam VH, Rybak MJ. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center. Clin Infect Dis. 2002;34(7):922\u20139. https:\/\/doi.org\/10.1086\/339211. Epub 2002 Mar 4. PMID: 11880957.","journal-title":"Clin Infect Dis"},{"key":"6808_CR35","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/430909","volume":"41","author":"CA Diaz Granados","year":"2005","unstructured":"Diaz Granados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis. 2005;41:327\u201333.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"6808_CR36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13756-025-01636-0","volume":"14","author":"C Sacco","year":"2025","unstructured":"Sacco C, Iacchini S, Isonne C, Iera J, Boros S, Fadda G, Errico G, Grosso MD, Monaco M, D\u2019Ancona F, Pezzotti P. Temporal trend and individual and hospital characteristics associated to vancomycin-resistant Enterococcus faecium bloodstream infections: a retrospective analysis from the national surveillance system, Italy 2015\u20132023. Antimicrob Resist Infect Control. 2025;14(1):120. https:\/\/doi.org\/10.1186\/s13756-025-01636-0. PMID: 41088440; PMCID: PMC12523168.","journal-title":"Antimicrob Resist Infect Control"},{"key":"6808_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1086\/345744","volume":"36","author":"MC Birmingham","year":"2003","unstructured":"Birmingham MC, Rayner CR, Meagher AK, Flavin SM, Batts DH, Schentag JJ. Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. Clin Infect Dis. 2003;36:159\u201368.","journal-title":"Clin Infect Dis"},{"key":"6808_CR38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ijid.2023.01.035","volume":"129","author":"ST Huang","year":"2023","unstructured":"Huang ST, Yang JL, Lin CY, et al. Risk factors for mortality after linezolid treatment of vancomycin-resistant Enterococcus bloodstream infection. Int J Infect Dis. 2023;129:96\u2013102.","journal-title":"Int J Infect Dis"},{"key":"6808_CR39","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/cid\/civ444","volume":"61","author":"NS Britt","year":"2015","unstructured":"Britt NS, Potter EM, Patel N, Steed ME. Comparison of the effectiveness and safety of linezolid and daptomycin in vancomycin-resistant enterococcal bloodstream infection: A national cohort study of Veterans Affairs patients. Clin Infect Dis. 2015;61:871\u20138.","journal-title":"Clin Infect Dis"},{"key":"6808_CR40","doi-asserted-by":"publisher","first-page":"e8901","DOI":"10.1016\/j.cmi.2016.07.018","volume":"22","author":"YC Chuang","year":"2016","unstructured":"Chuang YC, Lin HY, Chen PY, Lin CY, Wang JT, Chang SC. Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose. Clin Microbiol Infect. 2016;22:e8901\u20137.","journal-title":"Clin Microbiol Infect"},{"key":"6808_CR41","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jmii.2017.08.025","volume":"51","author":"JJ Ye","year":"2018","unstructured":"Ye JJ, Shie SS, Cheng CW, Yang JH, Huang PY, Wu TS, et al. Clinical characteristics and treatment outcomes of vancomycin-resistant Enterococcus faecium bacteremia. J Microbiol Immunol Infect. 2018;51:705\u201316.","journal-title":"J Microbiol Immunol Infect"},{"key":"6808_CR42","first-page":"364","volume":"27","author":"ER Del Turco","year":"2021","unstructured":"Del Turco ER, Bartoletti M, Dahl A, Cervera C, Peric\u00e0s JM. How Do I Manage a Patient with Enterococcal Bacteraemia? Clin. Microbiol Infect. 2021;27:364\u201371.","journal-title":"Microbiol Infect"},{"key":"6808_CR43","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.ajic.2016.02.017","volume":"44","author":"AM Lagnf","year":"2016","unstructured":"Lagnf AM, Zasowski EJ, Claeys KC, Casapao AM, Rybak MJ. Comparison of Clinical Outcomes and Risk Factors in Polymicrobial versus Monomicrobial Enterococcal Bloodstream Infections. Am J Infect Control. 2016;44:917\u201321.","journal-title":"Am J Infect Control"},{"key":"6808_CR44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1017\/ice.2015.228","volume":"37","author":"C Prematunge","year":"2016","unstructured":"Prematunge C, MacDougall C, Johnstone J, Adomako K, Lam F, Robertson J, Garber G. VRE and VSE Bacteremia Outcomes in the Era of Effective VRE Therapy: A Systematic Review and Meta-Analysis. Infect Control Hosp Epidemiol. 2016;37:26\u201335.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"6808_CR45","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41579-018-0107-z","volume":"17","author":"JH Ch\u2019ng","year":"2019","unstructured":"Ch\u2019ng JH, Chong KKL, Lam LN, Wong JJ, Kline KA. Biofilm-Associated Infection by Enterococci. Nat Rev Microbiol. 2019;17:82\u201394.","journal-title":"Nat Rev Microbiol"},{"key":"6808_CR46","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1093\/clinids\/23.6.1234","volume":"23","author":"MB Edmond","year":"1996","unstructured":"Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis. 1996;23:1234\u20139.","journal-title":"Clin Infect Dis"},{"key":"6808_CR47","doi-asserted-by":"publisher","first-page":"E181","DOI":"10.1111\/1469-0691.12132","volume":"19","author":"AL Cheah","year":"2013","unstructured":"Cheah AL, Spelman T, Liew D, Peel T, Howden BP, Spelman D, et al. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. Clin Microbiol Infect. 2013;19:E181\u20139.","journal-title":"Clin Microbiol Infect"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-06808-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06808-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06808-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T23:39:17Z","timestamp":1779406757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-06808-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6808"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-06808-4","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this retrospective study was obtained from the Ethics Committee of Hacettepe University in two separate time periods: the first approval was granted in January 2022 (Approval No: GO 22\/40), and the second in March 2025 (Approval No: SBA 25\/243).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"468"}}